ARDM
Aradigm Corporation
NasdaqCM
People also watch:ARQLEMISNKTRAEGNLJPC
4.71-0.00 (-0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close4.71
Open0.00
Bid0.00 x
Ask13.77 x 1600
52wk Range2.60 - 7.90
Day's Range4.71 - 4.71
Volume1,980
Avg Vol (3m)6,604
As of 3:46 PM EDT. Market closed.
  • Aradigm Corp. :ARDM-US: Earnings Analysis: Q1, 2016 By the Numbers
    Capital Cube2 months ago

    Aradigm Corp. :ARDM-US: Earnings Analysis: Q1, 2016 By the Numbers

    Click here to see latest analysisAradigm Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Aradigm Corp. – Alexza Pharmaceuticals, Inc., Windtree Therapeutics, Inc., MannKind Corporation, GlaxoSmithKline plc Sponsored ADR, Pfizer Inc., Johnson & Johnson, Innoviva, Inc., Insmed Incorporated and Gilead Sciences, Inc. (ALXA-US, […] (Read more...) The post Aradigm Corp. :ARDM-US: Earnings Analysis: Q1, 2016 By the Numbers appeared first on CapitalCube.

  • Associated Press2 months ago

    Aradigm reports 1Q loss

    The Hayward, California-based company said it had a loss of 55 cents per share. The specialty pharmaceutical company posted revenue of $6 million in the period. The company's shares closed at $4.61. A ...